ARG1 and ovarian carcinoma: For instance, Czystowska-Kuzmicz et al. [48] have confirmed that ovarian cancer cells use TEVs to deliver the metabolic checkpoint factor ARG1 to DCs in LNs, hence inhibiting antigen-specific T cell proliferation.